TATVA CHINTAN PHARMA CHEM
Back to Balance Sheet
|
TATVA CHINTAN PHARMA CHEM Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹-11 Cr | ₹-10 Cr | ₹-11 Cr | ₹5.06 Cr | ₹31 Cr |
What is the latest Total Non-Current Liabilities ratio of TATVA CHINTAN PHARMA CHEM ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹-11 Cr |
| Mar2024 | ₹-10 Cr |
| Mar2023 | ₹-11 Cr |
| Mar2022 | ₹5.06 Cr |
| Mar2021 | ₹31 Cr |
How is Total Non-Current Liabilities of TATVA CHINTAN PHARMA CHEM Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-11 Cr | Negative | |
| Mar2024 | ₹-10 Cr | Negative | |
| Mar2023 | ₹-11 Cr | Negative | |
| Mar2022 | ₹5.06 Cr | -83.58 | |
| Mar2021 | ₹31 Cr | - | |
Compare Total Non-Current Liabilities of peers of TATVA CHINTAN PHARMA CHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TATVA CHINTAN PHARMA CHEM | ₹2,921.3 Cr | 5.2% | 2.2% | 37.8% | Stock Analytics | |
| SOLAR INDUSTRIES INDIA | ₹167,605.0 Cr | 4.1% | -0.3% | 8% | Stock Analytics | |
| PIDILITE INDUSTRIES | ₹162,656.0 Cr | -0.1% | 8.8% | 6.3% | Stock Analytics | |
| SRF | ₹82,807.8 Cr | 4.8% | 2.8% | -10.7% | Stock Analytics | |
| GUJARAT FLUOROCHEMICALS | ₹43,523.7 Cr | 2.5% | 8.6% | 12.1% | Stock Analytics | |
| GODREJ INDUSTRIES | ₹40,731.5 Cr | 4.8% | 14.6% | -3% | Stock Analytics | |
TATVA CHINTAN PHARMA CHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TATVA CHINTAN PHARMA CHEM | 5.2% |
2.2% |
37.8% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses